MoneyWorks4Me

Shilpa Medicare - Quaterly Results

08 Aug 2024 Evaluate
The company witnessed a 14.78% growth in the revenue at Rs. 961.19 millions for the quarter ended June 2024 as compared to Rs. 837.41 millions during the year-ago period.The company almost doubled its revenue to Rs. 283.50 millions  from Rs. 79.00 millions in the quarter ended June 2024.Operating profit for the quarter ended June 2024 rose to 554.04 millions as compared to 361.21 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 961.19 837.41 14.78 961.19 837.41 14.78 3097.87 2477.02 25.06
Other Income 314.54 207.82 51.35 314.54 207.82 51.35 891.16 686.44 29.82
PBIDT 554.04 361.21 53.38 554.04 361.21 53.38 1154.08 246.42 368.34
Interest 19.49 67.60 -71.17 19.49 67.60 -71.17 172.57 208.25 -17.13
PBDT 529.95 230.24 130.17 529.95 230.24 130.17 877.00 -117.30 -847.66
Depreciation 123.02 122.63 0.32 123.02 122.63 0.32 496.11 465.48 6.58
PBT 406.93 107.61 278.15 406.93 107.61 278.15 380.89 -582.78 -165.36
TAX 123.43 28.61 331.42 123.43 28.61 331.42 111.52 -87.93 -226.83
Deferred Tax 11.39 9.81 16.11 11.39 9.81 16.11 -1.35 -4.27 -68.38
PAT 283.50 79.00 258.86 283.50 79.00 258.86 269.37 -494.85 -154.43
Equity 97.79 86.80 12.66 97.79 86.80 12.66 86.80 86.80 0.00
PBIDTM(%) 57.64 43.13 33.63 57.64 43.13 33.63 37.25 9.95 274.48
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..